The intestinal microbiota associated with cardiac valve calcification differs from that of coronary artery disease

Zuheng Liu1, Jiaying Li1, Haiyue Liu2

  • 1State Key Laboratory of Organ Failure Research, Department of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou, China; Key Laboratory for Organ Failure Research, Ministry of Education of the People's Republic of China, Guangzhou, China.

Atherosclerosis
|March 22, 2019
PubMed

Insights

Gut microbiome differences were found in cardiac valve calcification (VC) and coronary artery disease (CAD) patients. These gut bacteria may be potential therapeutic targets for cardiovascular disease (CVD).

Area of Science:

  • Microbiology
  • Cardiovascular Medicine
  • Genomics

Background:

  • Cardiac valve calcification (VC) and coronary artery disease (CAD) share risk factors but differ clinically.
  • Intestinal bacteria are increasingly implicated in cardiovascular disease (CVD).
  • Gut microbiota may link to various CVDs despite similar risk factors.

Purpose of the Study:

  • To explore gut microbiomes in VC and CAD patients.
  • To determine connections between gut microbiota and VC/CAD.
  • To identify potential microbial biomarkers and therapeutic targets.

Main Methods:

  • 16S rRNA gene sequencing was performed on samples from 119 subjects.
  • Analysis included VC patients, CAD patients, and control volunteers.
  • Gut microbiome beta-diversity was assessed.

Main Results:

  • Significant differences in gut microbiome beta-diversity were observed between VC and CAD patients.
  • Specific bacteria were enriched (e.g., Veillonella dispar) or decreased (e.g., Collinsella aerofaciens) in VC patients.
  • Prevotella copri and Collinsella aerofaciens were identified as potential keystone bacteria for VC and CAD, respectively.

Conclusions:

  • VC and CAD patients exhibit distinct gut microbial dysbiosis.
  • Gut microbiomes are associated with clinical characteristics of VC and CAD.
  • Gut microbiota represent potential therapeutic targets for these cardiovascular conditions.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.0K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
415
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
246
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
359
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
658
Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
87.2K